Local anesthetics are commonly used in peripheral nerve blockade for the management of postoperative and chronic pain. However, single administrations of conventional local anesthetics often result in nerve blocks that are short compared to the duration of postoperative care, and are often associated with local toxicity or systemic side effects. Consequently, there is considerable interest in developing longer-lasting and safer local anesthetic formulations.
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Introduction
Local anesthetics are commonly used in peripheral nerve blockade for management of postoperative pain. However, single administrations of conventional local anesthetics often result in nerve blocks that are short compared to the duration of postoperative care. 1 Moreover, local anesthetics frequently cause local toxicity affecting muscle 2 and peripheral nerves, 3 in direct relationship to their concentration and duration of exposure, as well as systemic toxicity affecting the cardiovascular 4 and central nervous systems. 5 Given these limitations, there is significant interest in developing local anesthetic formulations that can produce long lasting and safe nerve blocks.
Capsaicin (8- methyl-N-vanillyl-6-nonenamide), the active component of chili peppers, [6] [7] [8] produces sensory-selective analgesia. 6, 9, 10 It selectively binds to the TRPV1 ion channel, which is expressed on primary afferent nociceptors and enables their depolarization and excitation, leading to nociceptive responses; after initial excitation, prolonged exposure to capsaicin appears to desensitize the TRPV1 channel, resulting in analgesia. 9, [11] [12] [13] At low concentrations of capsaicin, nerve blockade is relatively brief.
However, the duration of capsaicin-induced nerve blocks can be prolonged by its coadministration with several other compounds, including bupivacaine, lidocaine, 14 amitriptyline, and others. 15 Among compounds that have been combined with capsaicin to achieve prolonged duration local anesthesia, site-1 sodium channel blockers, such as tetrodotoxin (TTX), are particularly remarkable for their ability to produce a truly synergistic prolongation of nerve blockade. 16 Due to their potent local anesthetic effect 17, 18 and minimal local toxicity to muscle and peripheral nerves, [18] [19] [20] site-1 sodium channel blockers are being investigated for clinical use. 21 While these compounds can cause considerable systemic toxicity at sufficiently large amounts, 22 this issue can be prevented by their encapsulation in liposomes and other particles, which act as sustained-release systems that slowly release small amounts of drug for long durations of time. [23] [24] [25] The synergy between TTX and capsaicin has been previously demonstrated 16 and has been attributed to the fact that capsaicin blocks TTX-resistant -but not TTX-sensitive -action potentials in some sensory nerve fibers, 16, 26 although this mechanism of synergy has not been fully 6 elucidated. Interestingly, but for unknown reasons, the prolonged nerve block resulting from this synergy has similar durations of sensory and motor nerve block.
Here, we hypothesized that the combined delivery of capsaicin and TTX by a sustained-release system can achieve prolonged nerve blocks and that selection of the appropriate dose of capsaicin would allow prolonged nerve block to be achieved in the absence of systemic or local toxicity. The latter is particularly important since at higher concentrations, nerve block from capsaicin can last for days or even be irreversible, 16 likely reflecting neurotoxicity with neuronal atrophy and degeneration; 10, [27] [28] [29] additionally, the risk of local toxicity is potentially increased by sustained release, as was the case for bupivacaine. 30 With these hypotheses in mind, we developed and characterized liposomes containing tetrodotoxin and capsaicin, then tested them in animals to determine their effect on nerve blockade and safety at different concentrations.
Finally, we co-injected the two liposome types and studied their combined effect on nerve blockade.
Methods

Animal care
Animals were cared for in accordance with protocols approved by the Boston Children's Hospital Institutional Animal Care and Use Committee and the guidelines of the International Association for the Study of Pain. 31 Adult male Sprague-Dawley rats (Charles River Laboratories, Wilmington, MA) weighing 325-400 g were housed in groups and kept in a 6 am -6 pm light-dark cycle.
Sciatic blockade technique
Rats were anesthetized with isoflurane-oxygen for < 5 minutes before receiving injections. A 23-G needle was introduced posteromedially to the greater trochanter, pointing anteromedially, and upon contact with the bone, 0.2 mL of liposome-or drugcontaining solution was injected. 23 The left leg was injected and used for blocks, and the right leg was not injected. Both legs were tested at each time point, as explained under 'Assessment of nerve blockade'.
Assessment of nerve blockade
The effectiveness of sensory and motor nerve blocks was measured at the following predetermined time points: 0h (before anesthesia), 0.5h, 1h, 2h, 4h, 8h, 12h, 18h, 24h, 48h, 72h, 96h, 120h, 144h, 168h, 192h, 216h, 240h, 264h, 288h, 312h, 336h. Sensory nerve block was examined by a modified hotplate test. 19, 32 The plantar surface of the rat's hind paw (in sequence; left, then right) was placed on a hotplate (IITC Inc., Woodland Hills, CA) preheated to 56°C, and the time until paw withdrawal (termed thermal latency) was recorded. Rats that did not withdraw their paw within 12 seconds were removed from the hotplate to avoid injury or development of hyperalgesia. Each paw was exposed to the hotplate three times at each time point. A median thermal latency above 7 seconds was considered a successful block, since that was the midpoint between maximal latency (12 seconds) and baseline, and nerve block duration was calculated as the time required for median thermal latency to return to 7 seconds from a higher value. Baseline latency has been previously determined by our group to be approximately 2 seconds. Irreversible blocks were defined as blocks not returning to baseline within 14 days of injection.
Motor nerve block was assessed by a weight-bearing test. The animal was positioned over a digital balance allowing it to bear its own weight with one hind paw at a time. The highest weight value the rat could bear without its ankle touching the balance was recorded. A borne weight below its half-maximal value was considered a successful motor block. Motor block duration was calculated as the time required for the borne weight to return halfway to its maximal value. 19 
Solutions of capsaicin and tetrodotoxin
Tetrodotoxin was dissolved in 20 mM citrate buffer, pH 4.45, to a concentration of 0.3 mM. Capsaicin was dissolved in Tween 80 at 55°C to a concentration of 330 mM.
These solutions were stored at 4°C and diluted in NaCl as needed. Capsaicin and TTX solutions were prepared by serial dilution of solutions with known weights/volume (mg/ml). In the text, we expressed their concentrations in molarity, so as to facilitate comparison to our previous work and the literature.
Liposome preparation
i. Capsaicin-loaded liposomes:
Capsaicin liposomes were produced by a modified thin lipid film method. 23, 24 Capsaicin (purity ≥ 95%, Sigma-Aldrich, St. Louis, MO) was mixed with a lipid formulation according to the following molar ratio: 2. ii. Tetrodotoxin-loaded liposomes:
Tetrodotoxin liposomes were also produced using a modified thin lipid film method, as previously reported. 23, 24 A lipid formulation at a molar ratio of 3 DSPC : 3 DLPC : 2 DSPG : 3 cholesterol was dissolved in a solution of 9 chloroform : 1 methanol, and vaporized. The solvent was then vaporized, and the resulting thin lipid film was redissolved in tert-butanol, followed by lyophilization. The resulting lipid cake was rehydrated in a solution of 0.3 mg/mL tetrodotoxin (Abcam, Cambridge, UK) in PBS.
After 10 freeze-thaw cycles, the solution was dialyzed against PBS for 24h in a dialysis tube with a molecular mass cutoff of 1000 kDa.
Liposome characterization
i. Drug loading:
The concentration of capsaicin loaded into liposomes was determined by highperformance liquid chromatography (Agilent 1260 Infinity, Agilent Technologies, Santa Clara, CA) after disruption of the liposomes with octyl β-D-glucopyranoside. 24, 33 The eluent was monitored at 280 nm with a flow rate of 1 mL/min. The concentration of TTX loaded into liposomes was determined by ELISA (Reagen, Moorestown, NJ).
ii. In-vitro drug release:
Solutions of capsaicin-loaded and TTX-loaded liposomes were placed into Slide-A-Lyzer MINI dialysis devices (Thermo Scientific, Columbia, MD) with a 20,000 MW cutoff. Samples were dialyzed against PBS and incubated at 37 o C on a platform shaker. At predetermined time points, the dialysate was collected and the dialysis solution was
replenished. The concentration of capsaicin was determined by HPLC, and the concentration of TTX was determined by ELISA.
iii. Size measurement:
Capsaicin-loaded and TTX-loaded liposomes were imaged by transmission electron microscopy (TEM) for morphology evaluation and size measurement. 10 µL of each liposomal solution was placed on a copper grid, and allowed to dry at room temperature.
Each sample was imaged on a Tecnai G2 Spirit BioTWIN transmission electron microscope (FEI, Hillsboro, OR) equipped with an AMT (Woburn, MA) 2k CCD camera, operating at 80 kV. Average liposome diameters and their standard deviations were calculated by measuring 100 liposomes of each type using the software ImageJ (NIH). Liposome diameters were also determined by dynamic light scattering (DLS).
Solutions of 0.3 mL of each liposome type were placed into disposable cuvettes (Eppendorf, Hauppauge, NY) and particle sizes were measured using a Delsa Nano C particle analyzer (Beckman Coulter, CA) operating at 25ºC.
Tissue harvesting and toxicity studies
Rats were euthanized with carbon dioxide 4 days after injection at the sciatic nerve.
The sciatic nerve and surrounding muscle tissue were dissected for histologic analysis by hematoxylin & eosin-and toluidine-blue staining, and for analysis by TEM.
The tissues were harvested and processed to produce H&E-stained slides, using standard techniques. The samples were scored for inflammation (0-4) and myotoxicity (0- To evaluate neurotoxicity, the sciatic nerve samples were processed for staining with toluidine blue and TEM, using standard techniques. Toluidine blue staining was done using standard techniques. Briefly, samples were fixed in 1.25% formaldehyde, 2.5% glutaraldehyde, and 0.03% picric acid in 0.1 M sodium cacodylate buffer, pH 7.4, treated with osmium tetroxide, stained with uranyl acetate, dehydrated in graded ethanol solutions, and infiltrated with a mixture of propylene oxide and TAAB 812 Resin (TAAB Laboratories, Calleva Park, UK). Tissues were then cut into 500 nm-thick sections, stained with toluidine blue, and reviewed in a masked fashion with high-resolution light microscopy. 24, 34 The stained nerve sections were evaluated for abnormalities in myelinated nerve fibers (decrease in density, perineurial edema) which included axon abnormalities (size variation, absence) and myelin sheath abnormalities (absence, thickening, splitting).
For transmission electron microscopy, sample fixation and treatment were similar to those for toluidine-blue staining. Samples were cut into thinner, 100 nm-thick sections, and mounted on a metal grid; each section contained ~40% of a sciatic nerve cross section.
The ultrastructural examination was performed with a JEOL 1200EX transmission electron microscope (JEOL, Tokyo, Japan), equipped with an AMT (Woburn, MA) 2k CCD camera, operating at 80 kV. For each sciatic nerve sample, 5 micrographs produced at magnifications of 1200X were used for counting myelinated and unmyelinated fibers, and for measuring fiber diameters. Average fiber diameters were calculated by measuring 100 fibers of each type.
Statistical analysis
In Figures 1B and 1E , the size of liposomes was depicted as histograms, and the corresponding data in the text were reported as the average diameter and standard deviation calculated by measuring 100 liposomes using the software ImageJ (NIH).
In Figures In Figures 2B and 4C , our test of normality indicated significant departure from normality, hence we applied the non-parametric Mann-Whitney-U test with Bonferroni adjustment for multiple comparisons, and report the corresponding data as medians and IQRs. In Figure 5 , where such departure from normality was not noted, nerve block data were reported as means and standard deviation [denoted throughout as mean (SD)] and were assessed using ANOVA with Bonferroni correction for multiple comparisons. 36 In Figure 6 , we used the F-test in ANOVA with Bonferroni adjustment for multiple comparisons.
In 
Results
Liposome production and characterization
Capsaicin liposomes were produced by a modified thin lipid film method 23, 24 (Table   1 ). TEM demonstrated that the liposomes were spherical ( Fig. 1A) and had an average diameter of 1.29 (0.41) µm ( Fig. 1B) . Measurements by DLS revealed an average diameter of 1.42 (0.33) µm. The liposomal encapsulation of capsaicin resulted in prolonged release of capsaicin compared to that of free capsaicin (Fig. 1C) .
Tetrodotoxin liposomes were also produced using a modified thin lipid film method 23, 24 (Table 1) 
Sciatic nerve block by free and liposomal capsaicin
A key design feature was to encapsulate capsaicin at the highest loading that would not cause nerve injury, to maximize the possible safe interaction with tetrodotoxin. To this end, we performed sciatic nerve injections in rats with 0.2 mL of either capsaicinloaded liposomes or free capsaicin, followed by neurobehavioral testing (Fig. 2) . Testing was done at 819 µM, 1637 µM, 3274 µM capsaicin, representing serial dilutions of capsaicin (in mass/volume, these were 250, 500, and 1000 µg/mL, respectively). Four animals were used for each experimental group. There were no statistically significant differences between capsaicin liposomes and the equivalent dose of free capsaicin in the incidence of successful reversible or irreversible nerve blocks ( Fig. 2A and 2C ; P > 0.99, Fisher's exact test), or in the median duration of nerve blocks ( Fig. 2B ; P = 0.69 for 819 µM, P = 0.68 for 1637 µM, and P = 0.20 for 3274 µM, Mann-Whitney U test). There were no motor deficits, and no animals died or exhibited contralateral deficits (right paw thermal latency above 7 s, which would indicate systemic drug distribution). As previously shown, irreversible blocks from injection of high amounts of capsaicin were characterized by an initial transient increase in thermal latency, followed by some degree of block resolution, then by a very longlasting increase in latency ( Fig. 3) . Additionally, no animals were observed to have any behavioral abnormalities after injection of pure perineural capsaicin, aside from thermal latency changes: they did not appear uncomfortable, and were noted to feed, breathe and walk normally. The highest concentration of liposomal capsaicin tested that did not result in any irreversible blocks was 819 µM capsaicin. While that concentration resulted in minimal nerve blocks, we hypothesized that it would provide synergy to prolong the duration of block from TTX liposomes. Therefore, all subsequent experiments were conducted using 819 µM capsaicin liposomes, termed LipoCAP-819.
Sciatic nerve block by free and liposomal tetrodotoxin
Another key design feature was to encapsulate tetrodotoxin at the highest loading that would not cause systemic toxicity, in order to maximize the possible safe interaction with capsaicin. We performed sciatic nerve injections in rats with either TTX-loaded liposomes or free TTX, followed by neurobehavioral testing. Four animals were used for each experimental group (Fig. 4 ).
Free TTX produced nerve blocks in a concentration-dependent manner, which is well established 19, 38, 39 , until 47 µM, above which most animals died (Fig. 4A ). The risk of adverse effects or death was noted to increase significantly with increases in free TTX concentration (Wald test = 24.1, P < 0.001 comparing 73 µM with all other concentrations). The highest concentration of free TTX that did not result in adverse effects (deficits in the contralateral leg or death) was 23 µM (Fig. 4A) , termed FreeTTX-23. This concentration produced a sensory block with a mean duration of 11 (23) minutes. Similarly to free TTX, increasing concentrations of TTX liposomes resulted in an increased risk of adverse effects or death (Wald test = 874.2, P < 0.001), with 314 µM resulting in significantly higher percentages of those effects than lower concentrations (P < 0.001 compared to 78.5 µM, P < 0.001 compared to 157 µM, P = 0.046 compared to 219 µM). The highest concentration of TTX liposomes that did not result in adverse effects was 157 µM TTX liposomes (Fig. 4B) , termed LipoTTX-157. This concentration produced a sensory block with mean duration of 22 (44) minutes. The tested concentrations of TTX liposomes and free TTX did not overlap (since encapsulation allows safe delivery of much more TTX, but also requires greater loading for therapeutic effect, as seen here). TTX liposomes were able to produce longer nerve block durations.
Sensory nerve block from tetrodotoxin liposomes co-injected with capsaicin liposomes
Having established the upper limits of safe dosing (i.e. without detectable adverse effects given our sample size) of the two liposome types, we tested them in combination.
In order to maintain constant the volume of injectate (0. 
Functional specificity of liposomal types
While injection of capsaicin-only formulations resulted in purely sensory blocks, formulations containing tetrodotoxin resulted in some degree of motor blockade. The 20 combination of 0.1 mL LipoCAP-819 with 0.1 mL LipoTTX-157 resulted in a motor block lasting 12.6 (4.9) hours, which was longer than that from both types of singlecompound injections (P < 0.001, ANOVA, n = 4 per group) ( Fig. 5B ). There was no statistically significant difference between the durations of sensory and motor block in any of the tetrodotoxin-containing formulations. 
Effect of free drugs on nerve block from liposome-encapsulated drugs
To demonstrate that encapsulation was important to the effect achieved by the liposome combination, we injected LipoCAP-819 with the highest concentration of free TTX that did not result in systemic toxicity (Fig. 4A ), 23 µM (FreeTTX-23), which alone provided a mean duration of nerve block of 11 (23) minutes with no contralateral deficits (Fig. 6A) . The combination achieved a mean duration of sensory block of 177 (66) minutes, which is much less than that from LipoCAP-819 combined with LipoTTX-157 (P = 0.004, F-test in ANOVA, n = 4).
LipoTTX-157 were then injected with the highest concentration of free capsaicin that did not result in irreversible block (Fig. 2C) , 819 µM (termed FreeCAP-819), which alone provided a mean duration of nerve block of 8 (17) minutes (Fig. 6B) . The combination achieved a mean duration of sensory block of 207 (278) minutes, which was also less than that from LipoCAP-819 combined with LipoTTX-157 (P = 0.012, F-test in ANOVA, n = 4).
These data showed that co-delivery of encapsulated drugs yielded longer nerve blockade than did delivery of single drugs (encapsulated or not) or single encapsulated drugs with the second drug free. 
Tissue reaction
The sciatic nerves and adjacent tissues of all animals were harvested 4 days after injection. Hematoxylin-eosin stained sections were prepared and scored for myotoxicity and inflammation. 39, 40 Two animals that received the liposome combination showed scattered lymphocytes and mild nuclear internalization within myocytes (Fig. 7A) ; the rest of the animals in that group showed no inflammation or myotoxicity, similarly to uninjected animals (Fig. 7B ). Animals injected with that combination had median inflammation and myotoxicity scores of 0.5 (ranges [0-1] and [0-2], respectively), with no statistically significant differences compared to uninjected animals ( Table 2 ). The combination of FreeTTX-23 and LipoCAP-819 revealed no apparent differences in histology and had low scores for inflammation [median 0 (range 0-1)] and myotoxicity [0 (0-1)], and so did the combination of FreeCAP-819 and LipoTTX-157 [inflammation 0
(0-1) and myotoxicity 0 (0-0)].
Sciatic nerve segments were also processed with toluidine-blue staining 34, 41 for more sensitive detection of potential neurotoxicity to myelinated nerve fibers. Nerve histology from animals co-injected with LipoCAP-819 and LipoTTX-157 showed no significant differences when compared to uninjected animals or any other groups in terms of axonal size, shape, distribution, and myelin thickness ( Fig. 7C and D) . Since TRPV1 agonists have been reported to cause damage primarily to unmyelinated fibers, 28 resulting in a decrease in their number 27 and diameter, 42 we also examined all sciatic nerves by TEM, a technique that enables clear visualization of both myelinated and unmyelinated fibers. 27, 42 Electron micrographs obtained from animals co-injected with LipoCAP-819 and LipoTTX-157 showed normal unmyelinated fibers, with no evidence of injury, such as swelling, disintegration, or dark-staining axoplasm. 42 In both treated and untreated groups, myelinated fibers were occasionally found to have deposits within axons or circular breaks within myelin sheaths ( Fig. 7E and F) , which are commonly reported electron-microscopic findings of normal peripheral nerve fibers. 42, 43 We calculated the percentage of unmyelinated fibers in sciatic nerve segments from animals that received the liposome combination and animals that were not injected, and quantified the average diameter of such fibers (Table 2 ). There was no statistically significant difference in the percentage or diameter of unmyelinated fibers between these two groups (P > 0.05 for both, ANOVA). To provide a positive control for nerve injury from capsaicin, we injected a group of animals with 0. 
Discussion
The co-injection of capsaicin liposomes and TTX liposomes led to a marked prolongation of nerve block, with blocks lasting approximately 18 hours. By way of comparison, in this same animal model, sensory block from 0.5% bupivacaine (w/v) solution lasts approximately 2-2.5 h, 19 and that from liposomal 1.33% bupivacaine lasts approximately 4 hours. 34 This block prolongation was greater than that achieved by capsaicin liposomes co-injected with free TTX or TTX liposomes co-injected with free capsaicin, demonstrating that encapsulation of both drugs was necessary for the observed effect. Additionally, tissue reaction to the combination of liposomes was benign. The percentage of unmyelinated fibers in our treated animals was no different from that of our non-injected control animals, which was consistent with existing literature for the normal rat sciatic nerve. 44 Importantly, neurotoxicity due to capsaicin, which has been widely reported, [27] [28] [29] 45, 46 was not seen. Given that TRPV1 agonists may induce neuronal degeneration as early as one day after their administration, 47, 48 the timing of our animal dissections (4 days) should have allowed detection of such degeneration. While capsaicin in solution has been commonly used for local anesthesia, including in combination with site-1 sodium channel blockers, [14] [15] [16] to our knowledge, this is the first time that capsaicin liposomes have been used for this purpose. Likewise, this is the first study in which a liposomal formulation achieving a significantly prolonged nerve block was shown to have no detectable toxicity by H&E, toluidine-blue staining and quantification of nerve fibers by TEM.
This study was partially inspired by previous work from our group demonstrating synergy between free capsaicin and free TTX in sciatic nerve blockade. 16 The exact mechanism of this synergy is not clear, but it is possible that capsaicin and TTX potentiate each other because they inhibit different populations of sodium currents, mediated by TTX-resistant and TTX-sensitive channels, respectively. In fact, Großkreutz et al. and Yoshimura et al., among others, have shown that capsaicin can block TTXresistant sodium potentials in C fibers, 26, 49 and Kwong and Lee showed that capsaicinsensitive pulmonary neurons have a higher percentage of TTX-resistant sodium currents than do capsaicin-insensitive pulmonary neurons. 50 When combined with conventional local anesthetics, capsaicin has been shown to prolong sensory-specific nerve blocks, by other groups. 14, 15 However, similarly to our previous findings on the combination of capsaicin and TTX, we found no significant predominance of either sensory or motor blockade in any of the studied groups in our current work.
This work was oriented toward studying the effect of formulation on nerve block duration. Another important metric is the onset of nerve blockade. We did not see any difference between groups in that metric, since the hind paw thermal latency was above 7s in all animals that developed blockade by the first tested time point. However, since that time point was 30 minutes after injection, it is possible that there were differences in onset that were not detected. For example, differences in onset between various site-1 sodium channel blockers and bupivacaine occur within the first ten minutes after injection. 38 One of our study's limitations is the relatively small sample sizes used for animal experiments. While we chose a sample size of four to detect only large differences in nerve block duration and toxicity, we recognize that smaller -and perhaps clinically significant -differences may have been missed. It is also possible that larger sample sizes would reveal some functional predominance to the nerve blocks produced by our formulations. Another limitation is our somewhat restricted ability to determine the safety of our formulations with certainty; while we did not detect significant toxicity using methods that are validated in the literature -observation of behavior, contralateral blocks or death, histology and TEM -it is possible that studies using different methods may be beneficial. For example, other methods of nerve characterization, including quantification of neuropeptides such as substance P or calcitonin gene-related peptide, 51,52 may show differences in nerve physiology after treatment with our formulations.
Our formulation could undergo modifications for enhanced performance in the clinical setting. We chose to use subclinical amounts of both drugs in part to facilitate the detection of their potential synergistic effect. However, the lack of toxicity detected in our animals indicates that these drug amounts may be further increased before appreciable toxicity occurs. In the case of TTX, which has a very limiting therapeutic index, future work may focus on combining an increase in drug dose with the use of a vehicle that releases the drug more slowly. In addition, an increased ratio of TTX to vehicle, without compromising release kinetics, may result in greater exposure of TTX to the nerve and further prolongation of nerve blockade.
This work suggests that capsaicin, and perhaps other compounds that act by a similar mechanism, may be used safely to prolong the duration of other encapsulated local anesthetics, particularly in formulations that include site-1 sodium channel blockers.
Prolonged duration local anesthesia has been achieved by encapsulating site-1 sodium channel blockers and/or conventional local anesthetics. 23, 24, 53 Those two classes of compounds show marked synergy in solution, 19 and once encapsulated. 24, 54 Co-delivery with adjuvantic compounds, such as glucocorticoid receptor agonists, α2-adrenergic agonists and other vasoconstrictors, free or encapsulated, singly or in combination, 55 can dramatically prolong nerve blockade. It remains to be seen which of these formulations will be enhanced by addition of capsaicin. In that context, it is important to be mindful that there may be a ceiling to the effect of capsaicin beyond which its loading will incur local toxicity.
Conclusion
In conclusion, we have demonstrated that the combined delivery of capsaicin and TTX using a sustained-release system can achieve prolonged duration local anesthesia.
Our formulation of combined drug-loaded liposomes has a number of properties that make it appealing for treating postoperative pain. In addition to prolonging the duration of analgesia otherwise produced by the administration of capsaicin only, TTX only, or other conventional local anesthetics, 16, 19, 56 our formulation is easily injectable and results in no detectable local or systemic toxicity. Furthermore, our formulation may offer an alternative to opiate analgesics, which are associated with severe side effects 57,58 and widespread misuse, abuse, addiction, and overdose. 59 This work paves the way for the development of newer, safer, and more effective local anesthetics for postoperative pain management and other clinical applications.
